why choose us

First received: December 01, 2022

Clinical Trial: R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ulcerative Colitis Chronic Mild

Study Type: INTERVENTIONAL


Official Title: A Single and Repeat Dosing Study of the Safety, Drug Exposure, and Clinical Activity of R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Brief Summary: The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-3750) in patients with mild to moderate ulcerative colitis.Patients will take an oral dosage of probiotic (R-3750) and provide patient-reported and physician scored measures of their colitis.Blood and fecal evaluations of inflammation and assessment of probiotic (R-3750) on fecal levels will also be measured.

Read more